Old Web
English
Sign In
Acemap
>
authorDetail
>
Keisuke Yamamoto
Keisuke Yamamoto
Chugai Pharmaceutical Co.
Chemistry
Sodium/Glucose Cotransporter 2
SGLT2 Inhibitor
Type 2 diabetes
Biochemistry
4
Papers
169
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Development of a Scalable Synthesis of Tofogliflozin
2016
Journal of Organic Chemistry
Yoshihito Ohtake
Takashi Emura
Masahiro Nishimoto
Koji Takano
Keisuke Yamamoto
Satoshi Tsuchiya
Sang Yong Yeu
Yasushi Kito
Nobuaki Kimura
Sunao Takeda
Masao Tsukazaki
Masatoshi Murakata
Tsutomu Sato
Show All
Source
Cite
Save
Citations (18)
5a-Carba-β-D-glucopyranose derivatives as novel sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
2011
Bioorganic & Medicinal Chemistry
Yoshihito Ohtake
Tsutomu Sato
Hiroharu Matsuoka
Masahiro Nishimoto
Naoki Taka
Koji Takano
Keisuke Yamamoto
Masayuki Ohmori
Takashi Higuchi
Masatoshi Murakata
Takamitsu Kobayashi
Kazumi Morikawa
Nobuo Shimma
Masayuki Suzuki
Hitoshi Hagita
Kazuharu Ozawa
Koji Yamaguchi
Motohiro Kato
Sachiya Ikeda
Show All
Source
Cite
Save
Citations (16)
1